Literature DB >> 11779240

Folding of the yeast prion protein Ure2: kinetic evidence for folding and unfolding intermediates.

Despina Galani1, Alan R Fersht, Sarah Perrett.   

Abstract

The Saccharomyces cerevisiae non-Mendelian factor [URE3] propagates by a prion-like mechanism, involving aggregation of the chromosomally encoded protein Ure2. The N-terminal prion domain (PrD) of Ure2 is required for prion activity in vivo and amyloid formation in vitro. However, the molecular mechanism of the prion-like activity remains obscure. Here we measure the kinetics of folding of Ure2 and two N-terminal variants that lack all or part of the PrD. The kinetic folding behaviour of the three proteins is identical, indicating that the PrD does not change the stability, rates of folding or folding pathway of Ure2. Both unfolding and refolding kinetics are multiphasic. An intermediate is populated during unfolding at high denaturant concentrations resulting in the appearance of an unfolding burst phase and "roll-over" in the denaturant dependence of the unfolding rate constants. During refolding the appearance of a burst phase indicates formation of an intermediate during the dead-time of stopped-flow mixing. A further fast phase shows second-order kinetics, indicating formation of a dimeric intermediate. Regain of native-like fluorescence displays a distinct lag due to population of this on-pathway dimeric intermediate. Double-jump experiments indicate that isomerisation of Pro166, which is cis in the native state, occurs late in refolding after regain of native-like fluorescence. During protein refolding there is kinetic partitioning between productive folding via the dimeric intermediate and a non-productive side reaction via an aggregation prone monomeric intermediate. In the light of this and other studies, schemes for folding, aggregation and prion formation are proposed. Copyright 2002 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11779240     DOI: 10.1006/jmbi.2001.5234

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  7 in total

1.  Spectrin R16: broad energy barrier or sequential transition states?

Authors:  Kathryn A Scott; Jane Clarke
Journal:  Protein Sci       Date:  2005-06       Impact factor: 6.725

2.  Shifting transition states in the unfolding of a large ankyrin repeat protein.

Authors:  Nicolas D Werbeck; Pamela J E Rowling; Vasuki R Chellamuthu; Laura S Itzhaki
Journal:  Proc Natl Acad Sci U S A       Date:  2008-07-16       Impact factor: 11.205

3.  Thermodynamic and kinetic stability of a large multi-domain enzyme from the hyperthermophile Aeropyrum pernix.

Authors:  Mikael Karlström; Roberta Chiaraluce; Laura Giangiacomo; Ida Helene Steen; Nils-Kåre Birkeland; Rudolf Ladenstein; Valerio Consalvi
Journal:  Extremophiles       Date:  2010-03       Impact factor: 2.395

4.  Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein.

Authors:  Ulrich Baxa; Vladislav Speransky; Alasdair C Steven; Reed B Wickner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-16       Impact factor: 11.205

5.  The beta-strand-loop-beta-strand conformation is marginally populated in beta2-microglobulin (20-41) peptide in solution as revealed by replica exchange molecular dynamics simulations.

Authors:  Chungwen Liang; Philippe Derreumaux; Normand Mousseau; Guanghong Wei
Journal:  Biophys J       Date:  2008-04-11       Impact factor: 4.033

6.  A New Folding Kinetic Mechanism for Human Transthyretin and the Influence of the Amyloidogenic V30M Mutation.

Authors:  Catarina S H Jesus; Zaida L Almeida; Daniela C Vaz; Tiago Q Faria; Rui M M Brito
Journal:  Int J Mol Sci       Date:  2016-08-31       Impact factor: 5.923

7.  Direct Observation of Oligomerization by Single Molecule Fluorescence Reveals a Multistep Aggregation Mechanism for the Yeast Prion Protein Ure2.

Authors:  Jie Yang; Alexander J Dear; Thomas C T Michaels; Christopher M Dobson; Tuomas P J Knowles; Si Wu; Sarah Perrett
Journal:  J Am Chem Soc       Date:  2018-02-07       Impact factor: 15.419

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.